Ignite Creation Date:
2024-05-06 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 2:31 PM
Study NCT ID:
NCT05360238
Status:
TERMINATED
Last Update Posted:
2023-12-20
First Post:
2022-04-14
Brief Title:
Study to Assess Safety Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory B-Cell NHL or CLL
Sponsor:
Mustang Bio
Organization:
Mustang Bio
Conditions & Keywords Data
Conditions:
| Name |
|---|
| B-cell Lymphoma Refractory |
| Follicular B-cell Non-Hodgkins Lymphoma |
| Mantle Cell Lymphoma Recurrent |
| Mantle Cell Lymphoma Refractory |
| Small Lymphocytic Lymphoma Relapsed |
| Waldenstroms Macroglobulinemia Recurrent |
| Waldenstroms Macroglobulinemia Refractory |
| Chronic Lymphoid Leukemia in Relapse |
Keywords: